I’m almost speechless… almost.
The prize of a successful phase 2/3 trial is billions of dollars. Funding is absolutely critical to ensure the business can develop as many clinical assets as possible in the most efficient and fastest manner to ensure the greatest probability of success. And from my perspective it’s clear the board is prepared to make the difficult decisions to ensure the business is funded. 20.5 cents looks like a stroke of genius IMO.
I posted this earlier and it was moderated, supposedly at my request which is incorrect.
- Forums
- ASX - By Stock
- General discussion
I’m almost speechless… almost.The prize of a successful phase...
-
- There are more pages in this discussion • 2,926 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online